Three of the five top-selling drugs contain fluorine and in 2013, 9 of 27 new small molecules approved by the FDA for therapeutic use contained fluorine. Currently, due to a lack of synthetic methods inclusion of multiply fluorinated aryl groups on the central core of a drug scaffold is rare. Ongoing, selective mono- fluorination methods cannot address this issue. A conceptually attractive alternative is to utilize commercially available perfluoroarenes and selectively reduce or substitute the undesired fluorines. The goal of this proposal is develop synthetic methods will allow the perfluoroarenes to serve as linchpins for synthesis of multiply fluorinated drug scaffolds. To realize this goal we will activate the robust perfluoroarenes with an electron (Specific Aim 1) and via nucleophilic addition (Specific Aim 2). We will show that perfluoroarenes can undergo a number of C-C forming reactions that take place via C-F functionalization. We will also show that perfluoroarenes are also quite susceptible to nucleophilic addition by developing a number of substitution reactions that lead to biologically relevant motifs. Finally, we will develop novel catalysts that expand C-F functionalization strategies. The three aims are complimentary and synergistically approach the aforementioned problem. Upon completion of these aims, it is expected that medicinal chemists will be able to access and utilize polyfluorinated arenes with far greater ease and diversity than currently possible. This will positively influence the design o new pharmaceuticals by significantly expanding access to multiply-fluorinated arenes and significantly reducing the time needed to synthesize such molecules and, consequently, the time needed to discover new drugs.

Public Health Relevance

Multiply fluorinated arenes are an extremely important motif for current and future pharmaceuticals. Currently, this is a very difficult type of structure to access. Completion of this proposal will significantly improve our ability to access these molecules.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Synthetic and Biological Chemistry A Study Section (SBCA)
Program Officer
Yang, Jiong
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Oklahoma State University Stillwater
Schools of Arts and Sciences
United States
Zip Code
Saunders, Carla; Khaled, Mohammad B; Weaver 3rd, Jimmie D et al. (2018) Prediction of 19F NMR Chemical Shifts for Fluorinated Aromatic Compounds. J Org Chem 83:3220-3225
Teegardin, Kip A; Weaver, Jimmie D (2018) Preparation of Fac-Tris(2-Phenylpyridinato) Iridium(III). Organic Synth 95:29-45
Senaweera, Sameera; Weaver, Jimmie D (2017) SNAr catalysis enhanced by an aromatic donor-acceptor interaction; facile access to chlorinated polyfluoroarenes. Chem Commun (Camb) 53:7545-7548
Khaled, Mohammad B; El Mokadem, Roukaya K; Weaver 3rd, Jimmie D (2017) Hydrogen Bond Directed Photocatalytic Hydrodefluorination: Overcoming Electronic Control. J Am Chem Soc 139:13092-13101
Teegardin, Kip A; Weaver, Jimmie D (2017) Polyfluoroarylation of oxazolones: access to non-natural fluorinated amino acids. Chem Commun (Camb) 53:4771-4774
Day, Jon I; Weaver, Jimmie D (2017) Selective and Scalable Perfluoroarylation of Nitroalkanes. J Org Chem 82:6801-6810
Day, Jon I; Teegardin, Kip; Weaver, Jimmie et al. (2016) Advances in Photocatalysis: A Microreview of Visible Light Mediated Ruthenium and Iridium Catalyzed Organic Transformations. Org Process Res Dev 20:1156-1163
Senaweera, Sameera; Weaver, Jimmie D (2016) Dual C-F, C-H Functionalization via Photocatalysis: Access to Multifluorinated Biaryls. J Am Chem Soc 138:2520-3
Singh, A; Fennell, C J; Weaver, J D (2016) Photocatalyst size controls electron and energy transfer: selectable E/Z isomer synthesis via C-F alkenylation. Chem Sci 7:6796-6802
Senaweera, Sameera; Weaver, Jimmie D (2016) Photocatalytic C-F Reduction and Functionalization. Aldrichimica Acta 49:45-54